- Home
- GRBK vs MLTX Comparison
GRBK vs MLTX Comparison
Compare GRBK & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRBK
- MLTX
- Stock Information
- Founded
- GRBK 2006
- MLTX 2021
- Country
- GRBK United States
- MLTX Switzerland
- Employees
- GRBK N/A
- MLTX N/A
- Industry
- GRBK Homebuilding
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- GRBK Consumer Discretionary
- MLTX Health Care
- Exchange
- GRBK Nasdaq
- MLTX Nasdaq
- Market Cap
- GRBK 2.6B
- MLTX 2.8B
- IPO Year
- GRBK N/A
- MLTX N/A
- Fundamental
- Price
- GRBK $66.72
- MLTX $49.00
- Analyst Decision
- GRBK Buy
- MLTX Strong Buy
- Analyst Count
- GRBK 2
- MLTX 7
- Target Price
- GRBK $71.00
- MLTX $73.33
- AVG Volume (30 Days)
- GRBK 246.0K
- MLTX 463.2K
- Earning Date
- GRBK 07-30-2025
- MLTX 08-06-2025
- Dividend Yield
- GRBK N/A
- MLTX N/A
- EPS Growth
- GRBK 26.03
- MLTX N/A
- EPS
- GRBK 8.31
- MLTX N/A
- Revenue
- GRBK $2,149,226,000.00
- MLTX N/A
- Revenue This Year
- GRBK N/A
- MLTX $103.42
- Revenue Next Year
- GRBK $9.93
- MLTX N/A
- P/E Ratio
- GRBK $8.04
- MLTX N/A
- Revenue Growth
- GRBK 21.22
- MLTX N/A
- 52 Week Low
- GRBK $50.57
- MLTX $31.42
- 52 Week High
- GRBK $84.66
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- GRBK 63.00
- MLTX 63.01
- Support Level
- GRBK $62.93
- MLTX $46.37
- Resistance Level
- GRBK $68.17
- MLTX $49.29
- Average True Range (ATR)
- GRBK 2.25
- MLTX 1.85
- MACD
- GRBK 0.32
- MLTX 0.05
- Stochastic Oscillator
- GRBK 81.90
- MLTX 88.30
About GRBK Green Brick Partners Inc.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.